William P. Vaughan

4.5k total citations
89 papers, 2.8k citations indexed

About

William P. Vaughan is a scholar working on Hematology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, William P. Vaughan has authored 89 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Hematology, 24 papers in Oncology and 16 papers in Pathology and Forensic Medicine. Recurrent topics in William P. Vaughan's work include Hematopoietic Stem Cell Transplantation (23 papers), Acute Myeloid Leukemia Research (15 papers) and Lymphoma Diagnosis and Treatment (12 papers). William P. Vaughan is often cited by papers focused on Hematopoietic Stem Cell Transplantation (23 papers), Acute Myeloid Leukemia Research (15 papers) and Lymphoma Diagnosis and Treatment (12 papers). William P. Vaughan collaborates with scholars based in United States, Canada and Belgium. William P. Vaughan's co-authors include Anne Kessinger, Philip J. Burke, Jamés O. Armitage, Judith E. Karp, William G. Merz, Rein Saral, Gail L. Woods, Richard Robbins, Marlin G. Stahl and Helen M. Haupt and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

William P. Vaughan

88 papers receiving 2.7k citations

Peers

William P. Vaughan
Roy S. Weiner United States
Andreas Hirt Switzerland
Michael Kiehl Germany
Hyoung Jin Kang South Korea
Stefano Tarantolo United States
U. Jehn Germany
Liat Vidal Israel
R. De Bock Belgium
A. H. Goldstone United Kingdom
Hartmut Link Germany
Roy S. Weiner United States
William P. Vaughan
Citations per year, relative to William P. Vaughan William P. Vaughan (= 1×) peers Roy S. Weiner

Countries citing papers authored by William P. Vaughan

Since Specialization
Citations

This map shows the geographic impact of William P. Vaughan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William P. Vaughan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William P. Vaughan more than expected).

Fields of papers citing papers by William P. Vaughan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William P. Vaughan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William P. Vaughan. The network helps show where William P. Vaughan may publish in the future.

Co-authorship network of co-authors of William P. Vaughan

This figure shows the co-authorship network connecting the top 25 collaborators of William P. Vaughan. A scholar is included among the top collaborators of William P. Vaughan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William P. Vaughan. William P. Vaughan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sabbatini, Amber K., Lisa H. Merck, Adam T. Froemming, et al.. (2015). Optimizing Patient‐centered Communication and Multidisciplinary Care Coordination in Emergency Diagnostic Imaging: A Research Agenda. Academic Emergency Medicine. 22(12). 1427–1434. 12 indexed citations
2.
Kanzaria, Hemal K., Aileen McCabe, Annie LeBlanc, et al.. (2015). Advancing Patient‐centered Outcomes in Emergency Diagnostic Imaging: A Research Agenda. Academic Emergency Medicine. 22(12). 1435–1446. 28 indexed citations
3.
Vaughan, William P., Stéphan Busque, Jeffrey L. Veale, et al.. (2011). Managing Finances of Shipping Living Donor Kidneys for Donor Exchanges. American Journal of Transplantation. 11(9). 1810–1814. 11 indexed citations
4.
Su, H. Irene, Robert J. Gray, Phyllis A. Gimotty, et al.. (2010). Cyclophosphamide- metabolizing enzyme polymorphisms and survival outcomes after adjuvant chemotherapy for node-positive breast cancer: a retrospective cohort study. Breast Cancer Research. 12(3). R26–R26. 59 indexed citations
5.
DeMichele, Angela, Robert P. Gray, Jinbo Chen, et al.. (2009). Host Genetic Variants in the Interleukin-6 Promoter Predict Poor Outcome in Patients with Estrogen Receptor-Positive, Node-Positive Breast Cancer. Cancer Research. 69(10). 4184–4191. 45 indexed citations
6.
7.
8.
Tallman, Martin S., Robert P. Gray, Nicholas J. Robert, et al.. (2003). Conventional Adjuvant Chemotherapy with or without High-Dose Chemotherapy and Autologous Stem-Cell Transplantation in High-Risk Breast Cancer. New England Journal of Medicine. 349(1). 17–26. 126 indexed citations
9.
10.
Andersson, Börje S., Timothy Madden, Hai T. Tran, et al.. (2000). Acute safety and pharmacokinetics of intravenous busulfan when used with oral busulfan and cyclophosphamide as pretransplantation conditioning therapy: A phase I study. Biology of Blood and Marrow Transplantation. 6(5). 548–554. 121 indexed citations
11.
Salzman, Donna, Adrienne Briggs, & William P. Vaughan. (1997). Bone Marrow Transplantation for Non-Hodgkin's Lymphoma: A Review. The American Journal of the Medical Sciences. 313(4). 228–235. 10 indexed citations
12.
Tracewell, William, Donald L. Trump, William P. Vaughan, David C. Smith, & Peter R. Gwilt. (1995). Population pharmacokinetics of hydroxyurea in cancer patients. Cancer Chemotherapy and Pharmacology. 35(5). 417–422. 33 indexed citations
13.
Rimerman, Ronald A., et al.. (1993). Improved high-performance liquid chromatographic analysis of intracellular deoxyribonucleoside triphosphate levels. Journal of Chromatography B Biomedical Sciences and Applications. 619(1). 29–35. 8 indexed citations
14.
Smith, David C., William P. Vaughan, Peter R. Gwilt, & Donald L. Trump. (1993). A phase I trial of high-dose continuous-infusion hydroxyurea. Cancer Chemotherapy and Pharmacology. 33(2). 139–143. 9 indexed citations
15.
Sisson, Joseph H., Austin B. Thompson, James R. Anderson, et al.. (1992). Airway Inflammation Predicts Diffuse Alveolar Hemorrhage during Bone Marrow Transplantation in Patients with Hodgkin Disease. American Review of Respiratory Disease. 146(2). 439–443. 30 indexed citations
16.
Haire, William D., Robert P. Lieberman, James A. Edney, et al.. (1990). Hickman catheter-induced thoracic vein thrombosis. Frequency and long-term sequelae in patients receiving high-dose chemotherapy and marrow transplantation. Cancer. 66(5). 900–908. 81 indexed citations
17.
Jagannath, Sundar, Jamés O. Armitage, K. A. Dicke, et al.. (1989). Prognostic factors for response and survival after high-dose cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation for relapsed Hodgkin's disease.. Journal of Clinical Oncology. 7(2). 179–185. 172 indexed citations
18.
Woods, Gail L., Jack Davis, & William P. Vaughan. (1988). Failure of the Sterile Air-Flow Component of a Protected Environment Detected by Demonstration of Chaetomium Species Colonization of Four Consecutive Immunosuppressed Occupants. Infection Control and Hospital Epidemiology. 9(10). 451–456. 10 indexed citations
19.
Thompson, Jon S., David Burnett, Robert A. Cormier, & William P. Vaughan. (1988). Plasma postheparin diamine oxidase activity. Diseases of the Colon & Rectum. 31(7). 529–532. 16 indexed citations
20.
Silberberg, Alan, John M. Ziriax, William E. Timberlake, & William P. Vaughan. (1987). COMMENTARY PROMPTED BY VAUGHAN'S REPLY TO SILBERBERG AND ZIRIAX. Journal of the Experimental Analysis of Behavior. 48(2). 341–346. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Roy S. Weiner Breakdown of academic impact, for papers by Andreas Hirt Breakdown of academic impact, for papers by Michael Kiehl Breakdown of academic impact, for papers by Hyoung Jin Kang Breakdown of academic impact, for papers by Stefano Tarantolo Breakdown of academic impact, for papers by U. Jehn Breakdown of academic impact, for papers by Liat Vidal Breakdown of academic impact, for papers by R. De Bock Breakdown of academic impact, for papers by A. H. Goldstone Breakdown of academic impact, for papers by Hartmut Link
Rankless by CCL
2026